Approximately, 80% of individuals diagnosed as definite TSC sufferers have been found to harbour pathogenic variants in TSC1 or TSC2. The majority of remaining patients were shown to be mosaics or bear deep intronic mutations, if not possessing genetic changes in promoter or untranslated regions of these genes11. The gene discussed is TSC2; the disease is tuberous sclerosis.